SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-368796
Filing Date
2015-11-06
Accepted
2015-11-05 21:06:27
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d93448d10q.htm 10-Q 446166
2 EX-31.1 d93448dex311.htm EX-31.1 8571
3 EX-31.2 d93448dex312.htm EX-31.2 8570
4 EX-32.1 d93448dex321.htm EX-32.1 4585
  Complete submission text file 0001193125-15-368796.txt   2752268

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nktr-20150930.xml EX-101.INS 372372
6 XBRL TAXONOMY EXTENSION SCHEMA nktr-20150930.xsd EX-101.SCH 38542
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nktr-20150930_cal.xml EX-101.CAL 56458
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nktr-20150930_def.xml EX-101.DEF 110069
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20150930_lab.xml EX-101.LAB 300821
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20150930_pre.xml EX-101.PRE 209181
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 151202291
SIC: 2834 Pharmaceutical Preparations